GO:0001935 endothelial cell proliferation: Vasculogenesis and Angiogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001935 endothelial cell proliferation describes the multiplication of endothelial cells, the thin flattened cells that line body cavities, blood vessels and lymph vessels.
• Endothelial cell proliferation is a tightly regulated process that must be balanced with quiescence; quiescent endothelial cells upregulate fatty acid beta-oxidation for vasculoprotection via redox homeostasis.
• Key signaling pathways controlling endothelial proliferation include HIF-1alpha/VEGF, GLUT1-ERK, and AQP1-dependent senescence regulation.
• Dysregulated endothelial cell proliferation contributes to tumor angiogenesis, corneal endothelial dysfunction, and age-related vascular pathology.
• Autophagy and lipid reprogramming are emerging regulators of endothelial cell regeneration and proliferative capacity.
• Accurate measurement of endothelial cell proliferation requires methods such as flow cytometry for simultaneous proliferation and cell cycle staging.
Description
Endothelial cell proliferation (GO:0001935) is the biological process by which endothelial cells multiply, leading to expansion of the endothelial cell population. Endothelial cells form the endothelium, a thin monolayer lining the interior surfaces of blood vessels, lymph vessels and body cavities, and their controlled proliferation is essential for vascular development, wound healing and tissue regeneration. This process is distinct from endothelial activation or migration and is defined by cell division and population expansion. Understanding endothelial cell proliferation is critical because its dysregulation underlies numerous pathological conditions, including tumor angiogenesis, corneal endothelial disease, and vascular aging. Recent studies have revealed that endothelial cell proliferation is not a default state but is actively suppressed in quiescent vasculature, where fatty acid beta-oxidation supports redox homeostasis and vasculoprotection. Moreover, endothelial cell senescence and autophagy intersect with proliferative control, as shown by AQP1-mediated regulation of senescence and autophagy behavior in endothelial regeneration. The HIF-1alpha/VEGF signaling axis and the noncanonical GLUT1-ERK pathway are established drivers of endothelial cell proliferation, while ESM1 has been implicated in protecting endothelial proliferation and lipid reprogramming. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to provide a research-grade overview of GO:0001935, its mechanisms, key genes, disease relevance, and experimental models for CRISPR-based investigation.
endothelial cell proliferation At A Glance
| GO ID | GO:0001935 |
|---|---|
| GO term | endothelial cell proliferation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Multiplication or reproduction of endothelial cells resulting in expansion of the endothelial cell population |
| Cell type involved | Endothelial cells, thin flattened cells lining body cavities, blood vessels and lymph vessels |
| Related processes | Angiogenesis, vasculogenesis, endothelial cell migration, endothelial cell senescence, autophagy |
| Key regulatory pathways | HIF-1alpha/VEGF, GLUT1-ERK, AQP1-mediated senescence, fatty acid beta-oxidation, autophagy |
| Disease relevance | Tumor angiogenesis, corneal endothelial dysfunction, vascular aging, cardiovascular disease |
What Is GO:0001935?
GO:0001935 endothelial cell proliferation is defined as the multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin, flattened cells that line the inside surfaces of body cavities, blood vessels and lymph vessels, collectively forming the endothelium. This biological process encompasses the cell cycle progression and division of endothelial cells, and it is distinct from related processes such as endothelial cell migration, differentiation, or apoptosis. The term is annotated under the biological_process aspect of the Gene Ontology and has no synonyms in the QuickGO database.
Why Is endothelial cell proliferation Important in Cell Biology?
Endothelial cell proliferation is fundamental to vascular biology because it governs the formation of new blood vessels during development, tissue repair and pathological angiogenesis. In quiescent adult vasculature, endothelial cells must maintain a low proliferative index while retaining the capacity to proliferate in response to injury or hypoxia; this balance is actively regulated by metabolic and redox pathways, including fatty acid beta-oxidation. Loss of proliferative control in endothelial cells contributes to tumor angiogenesis, where excessive endothelial proliferation supports tumor growth, and to corneal endothelial dysfunction, where insufficient proliferation leads to corneal edema and vision loss. Furthermore, endothelial cell senescence and autophagy are increasingly recognized as modulators of proliferative capacity and vascular regeneration. Therefore, understanding the molecular mechanisms of GO:0001935 is essential for developing targeted therapies in oncology, ophthalmology and cardiovascular medicine.
• Endothelial cell proliferation is required for angiogenesis during embryonic development and tissue repair.
• Quiescent endothelial cells actively suppress proliferation and upregulate fatty acid beta-oxidation for vasculoprotection.
• Dysregulated endothelial proliferation drives tumor angiogenesis and cancer progression.
• Corneal endothelial dysfunction results from inadequate endothelial cell proliferation and is a major cause of blindness.
• Endothelial cell senescence, regulated by AQP1, limits proliferative capacity and contributes to vascular aging.
• Autophagy modulates endothelial cell regeneration and influences proliferative responses.
• HIF-1alpha/VEGF signaling is a central driver of endothelial cell proliferation under hypoxia.
• The GLUT1-ERK axis mediates ascorbic acid-induced endothelial proliferation and corneal endothelial repair.
• ESM1 protects endothelial cell proliferation and regulates lipid reprogramming.
• Flow cytometry methods enable simultaneous measurement of endothelial cell proliferation and cell cycle stage for research and drug screening.
What Happens During endothelial cell proliferation?
Initiation and Cell Cycle Entry
In simple terms: Endothelial cells receive growth signals that push them from a resting state into active division.
Endothelial cell proliferation begins when quiescent endothelial cells receive mitogenic signals, such as VEGF, that activate signaling cascades including HIF-1alpha/VEGF and GLUT1-ERK. These pathways drive cells from G0/G1 into S phase, initiating DNA replication and commitment to division. In quiescent vasculature, this entry is actively suppressed by metabolic programs such as fatty acid beta-oxidation, which maintains redox homeostasis and prevents inappropriate proliferation. The balance between pro-proliferative and anti-proliferative signals determines whether endothelial cells remain quiescent or enter the cell cycle.
DNA Replication and Cell Cycle Progression
In simple terms: Once committed, endothelial cells copy their DNA and progress through the cell cycle checkpoints.
After entering S phase, endothelial cells replicate their genome and progress through G2 and M phases. Cell cycle progression in endothelial cells can be measured simultaneously with proliferation using flow cytometry, which allows researchers to distinguish cells in different cycle stages. This progression is influenced by metabolic status, as lipid reprogramming and fatty acid oxidation support the biosynthetic demands of dividing cells. ESM1 has been shown to protect endothelial cell proliferation and modulate lipid reprogramming, suggesting that metabolic adaptation is required for successful cell cycle progression.
Mitosis and Population Expansion
In simple terms: Endothelial cells divide into two daughter cells, increasing the total number of endothelial cells.
The culmination of endothelial cell proliferation is mitosis, resulting in two daughter cells and expansion of the endothelial cell population. This population expansion is the defining outcome of GO:0001935 and is essential for forming new blood vessels and repairing damaged endothelium. The rate of population expansion can be quantified using proliferation assays and flow cytometry-based methods that track cell division. In pathological states such as tumor angiogenesis, this expansion becomes excessive, while in corneal endothelial dysfunction it is insufficient.
Regulation by Senescence and Autophagy
In simple terms: Cellular aging and recycling processes can put the brakes on endothelial cell division.
Endothelial cell proliferation is counterbalanced by senescence and autophagy. AQP1 differentially orchestrates endothelial cell senescence, and changes in AQP1 expression can shift endothelial cells toward a senescent, non-proliferative state. Autophagy behavior in endothelial cell regeneration also influences proliferative capacity, as autophagic flux can either support or limit endothelial cell renewal depending on context. These regulatory mechanisms ensure that endothelial proliferation is tightly controlled and reversible, preventing uncontrolled expansion while allowing regeneration after injury.
Metabolic and Redox Control
In simple terms: The way endothelial cells use fats and manage oxidative stress determines whether they divide or stay quiet.
Quiescent endothelial cells upregulate fatty acid beta-oxidation to maintain redox homeostasis and vasculoprotection, and this metabolic state is associated with low proliferative activity. When endothelial cells are stimulated to proliferate, metabolic reprogramming occurs, including changes in lipid metabolism regulated by ESM1. The GLUT1-ERK axis also links glucose metabolism to endothelial cell proliferation, as ascorbic acid enhances corneal endothelial proliferation via this noncanonical pathway. Thus, metabolic and redox signals are integral to the decision of endothelial cells to proliferate or remain quiescent.
Key Genes Involved in GO:0001935 endothelial cell proliferation
The following genes and proteins have been experimentally implicated in the regulation of endothelial cell proliferation (GO:0001935) according to verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AQP1 | Differentially orchestrates endothelial cell senescence | Regulates the balance between proliferation and senescence in endothelial cells |
| HIF-1alpha | Transcription factor activated by hypoxia | Drives VEGF signaling and endothelial cell proliferation under low oxygen |
| VEGF | Major angiogenic growth factor | Stimulates endothelial cell proliferation via HIF-1alpha/VEGF pathway |
| GLUT1 | Glucose transporter | Mediates ascorbic acid-induced endothelial proliferation via noncanonical ERK axis |
| ERK | Mitogen-activated protein kinase | Transduces proliferative signals downstream of GLUT1 in corneal endothelial cells |
| ESM1 | Endothelial cell-specific molecule 1 | Protects endothelial cell proliferation and regulates lipid reprogramming |
| CPT1A | Carnitine palmitoyltransferase 1A | Rate-limiting enzyme for fatty acid beta-oxidation in quiescent endothelial cells |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Involved in fatty acid beta-oxidation for endothelial redox homeostasis |
| HADHA | Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Supports fatty acid oxidation in quiescent endothelial cells |
| ATG5 | Autophagy-related 5 | Essential for autophagosome formation; modulates endothelial regeneration |
| ATG7 | Autophagy-related 7 | Required for autophagy; influences endothelial cell proliferative capacity |
| BECN1 | Beclin 1 | Regulates autophagy initiation in endothelial cells |
| CDKN1A | p21 cyclin-dependent kinase inhibitor | Cell cycle inhibitor that restrains endothelial proliferation |
| CDKN1B | p27 cyclin-dependent kinase inhibitor | Negative regulator of endothelial cell cycle progression |
| MKI67 | Marker of proliferation Ki-67 | Widely used marker to assess endothelial cell proliferation |
| PCNA | Proliferating cell nuclear antigen | Marker of DNA replication and endothelial proliferation |
| CCND1 | Cyclin D1 | Promotes G1/S transition in proliferating endothelial cells |
How Is endothelial cell proliferation Regulated?
Endothelial cell proliferation (GO:0001935) is regulated by a network of signaling pathways, metabolic checkpoints and stress-responsive mechanisms. The HIF-1alpha/VEGF axis is a central hypoxia-driven pathway that promotes endothelial proliferation by activating VEGF transcription and downstream mitogenic signaling. The noncanonical GLUT1-ERK axis mediates ascorbic acid-induced proliferation in corneal endothelial cells, linking glucose transport to MAPK signaling. Metabolic regulation is critical: quiescent endothelial cells upregulate fatty acid beta-oxidation to maintain redox homeostasis and suppress proliferation, while proliferating cells undergo lipid reprogramming regulated in part by ESM1. Senescence pathways, including AQP1-dependent regulation, can irreversibly limit proliferative capacity. Autophagy also modulates endothelial regeneration, with autophagy-related genes such as ATG5, ATG7 and BECN1 influencing proliferative responses. Together, these regulatory layers ensure that endothelial cell proliferation is context-dependent and tightly controlled.
endothelial cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIF1A | Tumor angiogenesis; hypoxia-driven endothelial proliferation | Knockout of HIF1A in endothelial cells followed by hypoxia exposure and proliferation assay |
| VEGFA | Angiogenesis; cancer and ischemic disease | Overexpression of VEGFA in endothelial cells to measure proliferative response |
| AQP1 | Vascular aging; endothelial senescence | Point mutation or knockout of AQP1 to assess senescence and proliferation balance |
| ESM1 | Tumor angiogenesis; lipid reprogramming | Knockout and overexpression of ESM1 in endothelial cells to measure proliferation and lipid metabolism |
| SLC2A1 (GLUT1) | Corneal endothelial dysfunction; ascorbic acid response | Knockout of GLUT1 in corneal endothelial cells to test ERK-dependent proliferation |
Endothelial Cell Proliferation in Tumor Angiogenesis
Excessive endothelial cell proliferation is a hallmark of tumor angiogenesis, where cancer cells secrete pro-angiogenic factors such as VEGF to stimulate endothelial cells to proliferate and form new blood vessels that supply the tumor. The HIF-1alpha/VEGF pathway is frequently activated in hypoxic tumor microenvironments, driving endothelial proliferation and tumor progression. ESM1, which protects endothelial cell proliferation and regulates lipid reprogramming, has been implicated in supporting tumor-associated endothelial biology. Targeting endothelial cell proliferation is therefore a major strategy in anti-angiogenic cancer therapy.
Corneal Endothelial Dysfunction and Proliferative Failure
The corneal endothelium is a monolayer of endothelial cells that maintains corneal transparency by regulating fluid transport. Unlike vascular endothelial cells, corneal endothelial cells have limited proliferative capacity in vivo, and their dysfunction leads to corneal edema and vision loss. Ascorbic acid ameliorates corneal endothelial dysfunction and enhances cell proliferation via the noncanonical GLUT1-ERK axis, highlighting a potential therapeutic approach to stimulate endothelial proliferation. Challenges in corneal endothelial cell culture, including maintaining proliferative capacity ex vivo, remain a barrier to cell-based therapies.
Vascular Aging and Endothelial Senescence
Age-related vascular dysfunction is associated with endothelial cell senescence and reduced proliferative capacity. AQP1 differentially orchestrates endothelial cell senescence, and dysregulation of AQP1 can promote a senescent phenotype that limits endothelial proliferation and impairs vascular repair. Autophagy behavior in endothelial cell regeneration also declines with age, contributing to reduced regenerative capacity. Quiescent endothelial cells rely on fatty acid beta-oxidation for redox homeostasis and vasculoprotection, and age-related metabolic changes may disrupt this protective program, further compromising endothelial proliferative reserve.
Endothelial Proliferation in Regenerative Medicine
Harnessing endothelial cell proliferation is central to regenerative medicine approaches for ischemic diseases, wound healing and tissue engineering. Autophagy modulation has been proposed to enhance endothelial cell regeneration and proliferative capacity. Metabolic regulators such as ESM1 and pathways involving fatty acid oxidation may be targeted to promote endothelial proliferation in ischemic tissues while maintaining redox balance. In corneal regeneration, ascorbic acid and GLUT1-ERK signaling represent potential strategies to expand corneal endothelial cells for transplantation.
From endothelial cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AQP1 alter endothelial cell proliferation and senescence? | AQP1 knockout endothelial cells with proliferation and senescence assays |
| Does HIF-1alpha drive endothelial proliferation under hypoxia? | HIF1A knockout or point-mutation endothelial cells exposed to hypoxia |
| Does ESM1 protect endothelial proliferation via lipid reprogramming? | ESM1 knockout and overexpression endothelial cell lines with lipid profiling |
| Does GLUT1 mediate ascorbic acid-induced corneal endothelial proliferation? | GLUT1 knockout corneal endothelial cells treated with ascorbic acid |
| Does autophagy modulate endothelial regeneration? | ATG5 or ATG7 knockout endothelial cells with autophagy flux and proliferation assays |
| Can fatty acid beta-oxidation suppression induce proliferation in quiescent endothelium? | CPT1A knockout or knockdown endothelial cells with redox and proliferation measurements |
How to Study the endothelial cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Proliferation and cell cycle stage | Quantifying endothelial cell proliferation after genetic perturbation |
| EdU or BrdU incorporation | DNA synthesis | Assessing S-phase entry in proliferating endothelial cells |
| Senescence-associated beta-galactosidase staining | Cellular senescence | Evaluating AQP1-dependent senescence in endothelial cells |
| Autophagy flux assay (LC3 turnover) | Autophagic activity | Determining autophagy effects on endothelial regeneration |
| Western blotting | Protein expression and phosphorylation | Measuring HIF-1alpha, VEGF, GLUT1, ERK activation |
| RNA-seq | Transcriptome-wide gene expression | Identifying pathways altered in endothelial proliferation |
| Lipidomics / metabolic flux | Lipid reprogramming and fatty acid oxidation | Assessing ESM1 and CPT1A effects on endothelial metabolism |
| Immunofluorescence | Protein localization and proliferation markers | Detecting Ki-67 or PCNA in endothelial monolayers |
Flow Cytometry for Proliferation and Cell Cycle Analysis
Flow cytometry enables simultaneous measurement of endothelial cell proliferation and cell cycle stage, allowing researchers to quantify the fraction of cells in G0/G1, S and G2/M phases. This method is essential for assessing the effects of genetic perturbations on endothelial cell proliferation (GO:0001935) and for screening compounds that modulate proliferative responses.
Metabolic and Redox Assays
Because endothelial cell proliferation is tightly linked to metabolic state, assays measuring fatty acid beta-oxidation, redox homeostasis and lipid reprogramming are critical. Quiescent endothelial cells upregulate fatty acid beta-oxidation for vasculoprotection, and disruption of this program can alter proliferative capacity. ESM1-dependent lipid reprogramming can be assessed using lipidomics and metabolic flux analysis.
Senescence and Autophagy Detection
Senescence-associated beta-galactosidase staining, p21/p27 expression analysis and autophagy flux assays (LC3 turnover, ATG protein levels) are used to evaluate the balance between proliferation and growth arrest in endothelial cells. AQP1-dependent senescence can be monitored to determine how genetic or pharmacological interventions shift endothelial cells toward or away from proliferation.
Gene Expression and Signaling Pathway Analysis
RNA-seq, qPCR and Western blotting are used to measure expression of key regulators such as HIF-1alpha, VEGF, GLUT1, ERK and ESM1 in endothelial cells under proliferative stimuli. Phospho-ERK and HIF-1alpha protein levels provide readouts of pathway activation, while proliferation markers such as MKI67 and PCNA confirm functional proliferative responses.
How CRISPR Can Be Used to Study GO:0001935 endothelial cell proliferation
Knockout
CRISPR knockout of genes such as AQP1, HIF1A, ESM1, SLC2A1 (GLUT1), ATG5 or CPT1A in endothelial cells allows researchers to determine whether these genes are required for endothelial cell proliferation (GO:0001935). For example, AQP1 knockout can shift endothelial cells toward senescence, while HIF1A knockout reduces hypoxia-induced proliferation. Knockout studies are essential for establishing causal roles in proliferation and for validating drug targets.
Point Mutation
CRISPR point mutation can be used to introduce specific amino acid substitutions that alter protein function without eliminating expression. For example, point mutations in AQP1 can dissect its differential role in endothelial senescence versus proliferation. Similarly, point mutations in ERK or GLUT1 can test the importance of specific phosphorylation or transport residues in ascorbic acid-induced endothelial proliferation. This approach is valuable for understanding structure-function relationships in endothelial proliferation regulators.
Knock-in
CRISPR knock-in of reporter tags or fluorescent proteins into endogenous loci such as MKI67 or PCNA enables real-time tracking of proliferating endothelial cells. Knock-in of tagged HIF1A or ESM1 allows chromatin immunoprecipitation and interaction studies to define how these factors regulate endothelial proliferation. Knock-in models are also useful for generating disease-relevant mutations identified in vascular disorders.
Overexpression
CRISPR overexpression (e.g., via CRISPRa or knock-in of a strong promoter) of pro-proliferative genes such as VEGFA, ESM1 or GLUT1 can enhance endothelial cell proliferation and rescue proliferative defects. Overexpression of ESM1 protects endothelial proliferation and alters lipid reprogramming, making it a candidate for therapeutic augmentation. Overexpression studies complement knockout approaches to establish sufficiency in driving GO:0001935.
How EDITGENE Supports endothelial cell proliferation Research
Researchers studying endothelial cell proliferation-related genes often need to determine whether a candidate gene is causally involved in proliferation, senescence, metabolic reprogramming or angiogenesis. EDITGENE provides end-to-end CRISPR services to generate precisely engineered endothelial cell models, enabling rigorous functional validation of genes implicated in GO:0001935.
Contact EDITGENE today to design your custom CRISPR model for endothelial cell proliferation research.
Frequently Asked Questions About endothelial cell proliferation
What is GO:0001935 endothelial cell proliferation?
GO:0001935 is the Gene Ontology term for the multiplication or reproduction of endothelial cells, resulting in expansion of the endothelial cell population. Endothelial cells are thin flattened cells lining body cavities, blood vessels and lymph vessels.
What genes are involved in endothelial cell proliferation?
Key genes include AQP1, HIF1A, VEGFA, SLC2A1 (GLUT1), ESM1, CPT1A, ATG5, ATG7, BECN1, MKI67 and PCNA, as shown in studies of endothelial senescence, hypoxia signaling, metabolic reprogramming and autophagy.
How is endothelial cell proliferation measured?
Flow cytometry can simultaneously measure endothelial cell proliferation and cell cycle stage, while EdU/BrdU incorporation, Ki-67 staining and proliferation assays quantify DNA synthesis and population expansion.
Why is endothelial cell proliferation important in cancer?
Excessive endothelial cell proliferation drives tumor angiogenesis, supplying oxygen and nutrients to tumors. The HIF-1alpha/VEGF pathway and ESM1-mediated lipid reprogramming are key mechanisms in tumor-associated endothelial proliferation.
What is the role of AQP1 in endothelial cell proliferation?
AQP1 differentially orchestrates endothelial cell senescence, and its dysregulation can shift endothelial cells toward a senescent, non-proliferative state, limiting vascular repair.
How does autophagy affect endothelial cell regeneration?
Autophagy behavior in endothelial cell regeneration modulates proliferative capacity, with autophagy-related genes such as ATG5, ATG7 and BECN1 influencing endothelial renewal.
What signaling pathways regulate endothelial cell proliferation?
Major pathways include HIF-1alpha/VEGF, the noncanonical GLUT1-ERK axis, fatty acid beta-oxidation for redox homeostasis, and AQP1-dependent senescence regulation.
Can CRISPR be used to study endothelial cell proliferation?
Yes. CRISPR knockout, point mutation, knock-in and overexpression models enable causal testing of genes such as AQP1, HIF1A, ESM1 and GLUT1 in endothelial cell proliferation.
What diseases are linked to endothelial cell proliferation?
Diseases include tumor angiogenesis, corneal endothelial dysfunction, vascular aging and ischemic conditions, where endothelial proliferation is either excessive or insufficient.
What is the role of ESM1 in endothelial cell proliferation?
ESM1 protects endothelial cell proliferation and regulates lipid reprogramming, suggesting it supports proliferative capacity through metabolic adaptation.
Conclusion
GO:0001935 endothelial cell proliferation is a fundamental biological process that governs vascular development, repair and pathological angiogenesis. Its regulation involves a complex interplay of hypoxia signaling, metabolic reprogramming, senescence and autophagy, with key genes such as AQP1, HIF1A, VEGFA, GLUT1, ESM1 and autophagy-related factors playing critical roles. Dysregulation of endothelial cell proliferation contributes to cancer, corneal endothelial dysfunction and vascular aging, making it a high-value target for therapeutic intervention. Advances in CRISPR-based models and flow cytometry methods now enable precise functional dissection of this process, supporting the discovery of novel regulators and drug candidates.
References
- 1. Shabanian K et al.. 2024. AQP1 differentially orchestrates endothelial cell senescence.. Redox Biol 76:103317 PMID: 39180980
- 2. Wongvisavavit R et al.. 2021. Challenges in corneal endothelial cell culture.. Regen Med 16(9):871-891 PMID: 34380324
- 3. Lynam EG et al.. 2022. Simultaneous Measurement of Endothelial Cell Proliferation and Cell Cycle Stage Using Flow Cytometry.. Methods Mol Biol 2475:223-228 PMID: 35451761
- 4. Ni J et al.. 2024. Catalpol regulates apoptosis and proliferation of endothelial cell via activating HIF-1α/VEGF signaling pathway.. Sci Rep 14(1):28327 PMID: 39550364
- 5. Hsueh YJ et al.. 2021. Ascorbic acid ameliorates corneal endothelial dysfunction and enhances cell proliferation via the noncanonical GLUT1-ERK axis.. Biomed Pharmacother 144:112306 PMID: 34656060
- 6. Kalucka J et al.. 2018. Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis.. Cell Metab 28(6):881-894.e13 PMID: 30146488
- 7. Li Y et al.. 2025. Unveiling the protective role of ESM1 in endothelial cell proliferation and lipid reprogramming.. Sci Rep 15(1):15572 PMID: 40320451
- 8. Marzoog BA. 2024. Autophagy Behavior in Endothelial Cell Regeneration.. Curr Aging Sci 17(1):58-67 PMID: 37861048
